13F-HR filed by Temasek Holdings (Private) Ltd
Temasek Holdings (Private) Ltd filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-16, with 26 holding rows worth $13,170,786,000.
- Accession
- 0001104659-16-096830
- Filer
- CIK 1021944
- Filed
- 2016-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2015
A holdings report, 26 entries on the cover page, a total value of $13,170,786,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $13,170,785,000 with VALUE read as thousands by filing date, 13F file number 028-13088. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerAranda Investments Pte. Ltd.
- included managerBaytree Investments (Mauritius) Pte Ltd 028-13096
- included managerCairnhill Investments (Mauritius) Pte Ltd 028-13098
- included managerDahlia Investments Pte. Ltd. 028-15196
- included managerDunearn Investments (Mauritius) Pte Ltd 028-14160
- included managerEsta Investments Pte. Ltd. 028-15912
- included managerEvans Investments Pte. Ltd.
- included managerFullerton Fund Investments Pte Ltd 028-15193
- included managerFullerton Management Pte Ltd 028-13103
- included managerHavelock Fund Investments Pte Ltd 028-15197
- included managerIxora Investments Pte. Ltd.
- included managerMaju Investments (Mauritius) Pte Ltd
- included managerMaxwell (Mauritius) Pte Ltd 028-15904
- included managerNorthbrooks Investments (Mauritius) Pte Ltd 028-14158
- included managerSeletar Investments Pte Ltd 028-13095
- included managerSennett Investments (Mauritius) Pte Ltd 028-15194
- included managerSherwood Investments Pte. Ltd. 028-14803
- included managerTemasek Capital (Private) Ltd 028-13090
- included managerTemasek Life Sciences Private Ltd 028-15907
- included managerTembusu Capital Pte. Ltd. 028-14163
- included managerThomson Capital Pte. Ltd. 028-15195
- included managerV-Sciences Investments Pte Ltd 028-15905
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 47,549,801 | $3,864,372,000 | thousands by filing date | |
| LEVEL 3 COMMUNICATIONS INC | 52729N308 | COM NEW | 65,031,667 | $3,535,121,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 12,794,924 | $1,294,718,000 | thousands by filing date | |
| MARKIT LTD | G58249106 | SHS | 21,173,310 | $638,799,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 2,899,315 | $411,268,000 | thousands by filing date | |
| UNIVAR INC | 91336L107 | COMMON STOCK | 22,636,684 | $385,050,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 3,472,712 | $363,801,000 | thousands by filing date | |
| E M C CORP MASS | 268648102 | COM | 14,141,103 | $363,144,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 6,583,568 | $338,725,000 | thousands by filing date | |
| VIRTU FINL INC | 928254101 | CL A | 12,317,682 | $278,872,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 1,226,630 | $233,980,000 | thousands by filing date | |
| VNET GROUP INC | 90138A103 | SPONSORED ADS A | 10,778,004 | $227,847,000 | thousands by filing date | |
| SYNCHRONYFINL | 87165B103 | STOK | 6,561,333 | $199,530,000 | thousands by filing date | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 6,096,878 | $196,716,000 | thousands by filing date | |
| PAYPALHLDGSINC | 70450Y103 | STOK | 5,387,963 | $195,044,000 | thousands by filing date | |
| TURQUOISE HILL RESOURCES LTD | 900435108 | COMMON STOCK-FO | 73,213,884 | $185,963,000 | thousands by filing date | |
| TUNIU CORP | 89977P106 | SPONSORED ADS | 8,194,444 | $130,947,000 | thousands by filing date | |
| AMYRIS INC | 03236M101 | COM | 69,592,216 | $112,739,000 | thousands by filing date | |
| MONSANTO CO NEW | 61166W101 | COM | 504,355 | $49,689,000 | thousands by filing date | |
| Q | 74876Y101 | Stock | 639,172 | $43,886,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 915,750 | $40,266,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 58,289 | $31,643,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 105,361 | $20,224,000 | thousands by filing date | |
| EROS INTL PLC | G3788M114 | SHS NEW | 1,376,000 | $12,590,000 | thousands by filing date | |
| MARIN SOFTWARE INC | 56804T106 | COM | 2,528,205 | $9,051,000 | thousands by filing date | |
| AMYRIS INC | 03236MAC5 | NOTE 6.500 5/1 | 10,000,000 | $6,800,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-16-096830 | this filing | 2016-02-16 | acceptance time not in the bulk data set |